Warnings
Some estrogens have been associated with bone marrow changes and an increased risk of mammary tumors. However, target animal safety study results and foreign post-market pharmacovigilance data for Incurin Tablets have shown that estriol-treated dogs are at low risk for developing these conditions.
Do not use on male dogs or intact females.
Precautions
Evaluation of factors contributing to urinary incontinence should be considered prior of administration of Incurin Tablets.
Do not use with other estrogens. The concomitant use of Incurin Tablets with other estrogens has not been evaluated.
The concomitant use of Incurin Tablets with glucocorticoids has not been evaluated.
The use of Incurin Tablets in dogs with liver disease has not been evaluated.
The safe use of Incurin Tablets has not been evaluated in intact female dogs, pregnant or lactating dogs, male dogs, and dogs less than 1 year of age.
Food and Drug Interactions
Many things might affect how well this drug will work in your animal including other drugs and suppliments. Be sure to discuss with your veterinarian so together you can make the best treatment decisions.
Human Warnings
Not for human use. Keep out of the reach of children. Women who are of childbearing age or those who are breastfeeding should use caution when administering Incurin Tablets. Wash your hands with soap and water after administration to avoid exposure to the drug. Consult a physician in case of accidental ingestion by humans.
